Evidence map›Paper›PMID 25934614›Full record

ArticleThe American journal of pathology2015

Biliary Epithelial Cells Are Not the Predominant Source of Hepatic CXCL12.

Yedidya Saiman, Tatsuki Sugiyama, Noa Simchoni, Carlo Spirli, Meena B Bansal

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Yedidya SaimanDivision of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Tatsuki SugiyamaDepartment of Immunobiology and Hematology, Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan.
Noa SimchoniDivision of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
Carlo SpirliLiver Center and Digestive Diseases Section, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
Meena B BansalDivision of Liver Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: meena.bansal@mssm.edu.
Icahn School of Medicine at Mount Sinai · USKyoto University · JPYale University · US

Funding

IL-6 regulation of matrix degradation in liver fibrosisK08DK060474 · NIDDK · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI BANSAL, MEENA B · 2002 to 2006
$641k
Stellate cell-HIV interactions and Hepatic FibrosisR56DK092128 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BANSAL, MEENA B · 2011 to 2011
$368k
Role of Matrix Metalloproteinase-2 in Liver FibrosisR03DK071745 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI BANSAL, MEENA B · 2006 to 2007
$167k
Biliary Epithelial Cell-derived SDF-1a in Hepatic Fibrogenesis and InflammationF30DK090986 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SAIMAN, YEDIDYA · 2011 to 2014
$143k
NIDDK NIH HHS DK-071745NIDDK NIH HHS DK-090986NIDDK NIH HHS DK-6047402NIDDK NIH HHS F30 DK090986NIDDK NIH HHS R03 DK071745NIDDK NIH HHS R56 DK092128NIDDK NIH HHS R56DK-092128
6 · The paper itself

Abstract

Hepatic expression levels of CXCL12, a chemokine important in inflammatory and stem cell recruitment, and its receptor, C-X-C chemokine receptor 4, are increased during all forms of liver injury. CXCL12 is expressed by both parenchymal and nonparenchymal hepatic cells, and on the basis of immunohistochemistry, biliary epithelial cells (BECs) are thought to be a predominant source of hepatic CXCL12, thereby promoting periportal recruitment of C-X-C chemokine receptor 4-expressing lymphocytes. Our study aims to show that BECs may, in fact, not be the predominant source of hepatic CXCL12. We measured CXCL12 secretion and expression from human and murine BECs using enzyme-linked immunosorbent assay and Western blot analysis from cell culture supernatants and whole cell lysates, respectively, whereas CXCL12 expression in murine livers was analyzed in a Cxcl12-Gfp reporter mouse. Cell culture supernatants and whole cell lysates from BECs failed to demonstrate their expression of CXCL12. Furthermore, we confirmed these results with a Cxcl12-Gfp reporter mouse in which green fluorescent protein expression is notably absent from BECs. Interestingly, on the basis of green fluorescent protein expression, we demonstrate a population of CXCL12-expressing cells within the portal tract that are distinct, yet intimately associated with BECs. These findings indicate that BECs are not a predominant source of CXCL12.

Indexed as

AnimalsBile Ducts, IntrahepaticCell LineChemokine CXCL12Enzyme-Linked Immunosorbent AssayEpithelial CellsGene ExpressionGenes, ReporterHumansLiverLymphocytesMiceMice, Inbred C57BLRecombinant Fusion ProteinsChemokine CXCL12CXCL12 protein, humanCxcl12 protein, mouseRecombinant Fusion Proteins

Identifiers

PMID25934614
PMCPMC4483462
OpenAlexW2134550069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.